Monique Gardner, MD is an attending physician in the Cardiac Intensive Care Unit at the Children’s Hospital of Philadelphia, and Assistant Professor of Anesthesiology and Critical Care and Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. Dr. Gardner came to Philadelphia for CHOP pediatrics residency after completing medical school at New York Medical College. She continued her CHOP training as a pediatric cardiology fellow, where she developed an interest in cardiac critical care and the care of infants with critical congenital heart disease. During her cardiology fellowship, she was awarded the Ann Newman Award, recognizing a second-year fellow for clinical excellence. Dr. Gardner then completed her critical care medicine training at the University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh, where she honed her care of children with critical illness, preparing herself for a career in CICU. She was recognized as Fellow of the Year before graduation, nominated by the pediatrics residents. She joined the CHOP CICU faculty in 2019. Dr. Gardner is board certified in pediatrics, pediatric cardiology, and pediatric critical care.
Dr. Gardner’s research focuses on children critically ill from cardiac disease, particularly neonates requiring surgery in the first weeks of life, and children recovering from cardiac arrest. She began her clinical research career as a cardiology fellow studying the impact of home monitoring on infants discharged after neonatal operations for single ventricle congenital heart disease. She has subsequently transitioned to focusing on plasma biomarkers that help identify neonates at risk for poor outcomes after cardiopulmonary bypass surgery and developing novel markers for risk assessment. Dr. Gardner is also exploring risk factors for mortality and neurologic impairment after pediatric cardiac arrest, in children with prior cardiac disease and those without. Given her training in echocardiography, and experience utilizing novel biomarkers, Dr. Gardner is examining the post-cardiac arrest state of inflammation and myocardial dysfunction. Dr. Gardner has published in the Journal of American Heart Association, American Journal of Cardiology, Pediatric Cardiology and Resuscitation.
- Identify the benefits of utilizing novel blood biomarkers to identify pre- and post-operative risk for neonates requiring cardiopulmonary bypass
- Explain the importance of recognizing post-cardiac arrest myocardial dysfunction and systemic inflammation and their impact on outcomes
This seminar was delivered as a Pediatric Grand Rounds Lecture at Children’s Hospital of Philadelphia, on May 11, 2022.
The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.
CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.
To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.
Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.
You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.
The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.
By starting this module, you agree to our Content Disclaimer and Terms of Service.